中文

科源制药 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-24
ItemAmountY/Y
Revenue¥0.16B+45.1%
Gross profit¥0.09B
Operating income¥0.03B
Net income¥0.03B+32.4%
Gross margin57.6%Net margin 18.9%
Revenue Q/Q+68.8%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.07B42.4%
R&D¥0.01B3.5%
SG&A¥0.05B32.5%
Tax & other¥0.00B1.8%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

金禄电子聚胶股份鸿日达侨源股份康力源清研环境国缆检测东星医疗明阳电气海科新源三博脑科美硕科技

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies